Inicio・Lista de Acciones・Compugen Ltd

Compugen Ltd

Cerrado

2.82 -1.74

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.79

Máximo

2.93

Métricas clave
By Trading Economics
Ingresos	663K -7M
Ventas	426K 2.6M
P/B Media del Sector	6.816 57.366
BPA	-0.07
Margen de beneficios	-269.254
Empleados	75
EBITDA	665K -7M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+74.22% upside

Dividendos
By Acuity
Próximas Ganancias	9 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	20M 245M
Apertura anterior	4.56
Cierre anterior	2.82

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

26 ago 2026, 23:56 UTC

Fluence Energy Inc shares are higher in after-market trading. Broader market context includes recent PCE price index data indicating ongoing inflationary pressures.

26 ago 2026, 23:56 UTC

Correlated Moves

Social Media

Tesla shares are trading higher in after-market hours, supported by increased institutional holdings from major investors and a broader market uptick.

26 ago 2026, 23:56 UTC

Shares of Stanley Black & Decker Inc rose modestly in after-market trading, settling at a cumulative return of 0.33% since Wednesday's close.

26 ago 2026, 23:56 UTC

Shares of Synchrony Financial are lower in after-market trading, moving from an early high to a low during the session.

26 ago 2026, 23:56 UTC

RTX Corp. shares are trading lower in after-market hours, with significant volatility noted since Wednesday's close and prices below the 20-day moving average.

26 ago 2026, 23:56 UTC

Macro Event

EUR/AUD trades lower as Australia's July inflation rate declines to 3.5%, exceeding expectations. The currency pair remains near the lower end of its one-month range.

26 ago 2026, 23:56 UTC

Ralph Lauren Corp shares are lower in after-market hours, continuing a trend from regular trading. The stock remains below its 20-day moving average.

26 ago 2026, 23:56 UTC

News

Constellation Brands reported first-quarter results that beat expectations, driven by beer sales. The company also reaffirmed EPS guidance and plans a $100 million investment.

26 ago 2026, 23:56 UTC

Cheniere Energy shares are trading lower in after-market hours. No specific news was identified to explain this price movement.

26 ago 2026, 23:52 UTC

AT&T Inc shares are lower in after-market hours with no specific news identified. Broader market data on rising consumer prices may influence investor sentiment.

26 ago 2026, 23:52 UTC

MARA Holdings Inc. shares are higher in after-market hours, supported by robust economic data and easing crude oil prices, reflecting a positive market trend.

26 ago 2026, 23:52 UTC

Correlated Moves

The SGD/CHF is trading higher, supported by a recent rise in USD/CHF. It remains near the upper end of its one-month trading range.

26 ago 2026, 23:52 UTC

The Swiss franc is trading lower against the South African rand during Wednesday's session, remaining near the lower end of its one-month range.

26 ago 2026, 23:51 UTC

The Nikkei 225 Index is trading higher in after-market hours, continuing a trend of upward movement following Wednesday's close.

26 ago 2026, 23:51 UTC

Ladder Capital Corp shares are higher in after-market trading, moving up from earlier lows and trading above its 20-day moving average. No specific news identified.

26 ago 2026, 23:51 UTC

Correlated Moves

Alpha and Omega Semiconductor rises in after-hours trading, recovering from an earlier dip. The stock advanced sharply since Wednesday's close, tracking semiconductor sector gains.

26 ago 2026, 23:51 UTC

Correlated Moves

PagerDuty Inc. shares are higher in after-market hours, driven by strong overall market momentum and Salesforce Inc.'s significant gain. Positive economic data supports this trend.

26 ago 2026, 23:51 UTC

Cabaletta Bio Inc shares are lower in after-market trading, following a decline earlier in the session. No specific news was identified to explain the movement.

26 ago 2026, 23:51 UTC

JetBlue Airways Corp shares are higher in after-market trading, reflecting broader market gains amid positive economic data on consumer prices and durable goods orders.

26 ago 2026, 23:51 UTC

Community Financial System Inc shares are higher in after-market hours, recovering from earlier lows. The stock remains below its 20-day moving average.

26 ago 2026, 23:51 UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

26 ago 2026, 23:51 UTC

Arbor Realty Trust is trading higher in after-market hours, advancing from Wednesday's close. Shares earlier pulled back but remain above the prior close.

26 ago 2026, 23:51 UTC

Yelp Inc shares are higher in after-market trading, recovering from an earlier dip. The stock remains below its 20-day moving average.

26 ago 2026, 23:51 UTC

PENN Entertainment Inc. shares rose in after-market trading, gaining modestly since Wednesday's close despite remaining below its 20-day moving average.

26 ago 2026, 23:51 UTC

U.S. markets gain momentum as inflation data reveals slight consumer price rise, while UK car production declines and copper prices surge amid strong demand.

26 ago 2026, 23:51 UTC

U.S. equity indices rise amid positive global sentiment and inflation data, while investors await Nvidia earnings and navigate geopolitical tensions affecting oil prices.

26 ago 2026, 23:51 UTC

Asia equity markets rise on falling crude oil prices and tech stock gains, while caution prevails ahead of U.S. inflation data and Fed Chair's speech.

26 ago 2026, 23:51 UTC

Mixed trading in European equities as easing inflation concerns clash with rising energy prices and UK economic woes.

26 ago 2026, 23:51 UTC

Brazil's Q2 GDP Growth Rate Expected to Rise by 0.8% Amidst Global Economic Challenges, Following a Strong 1.1% Expansion in Q1

26 ago 2026, 23:51 UTC

Market Cautiously Awaits Insights from Jackson Hole Symposium as Inflation Concerns and Fed Dissent Shape Economic Outlook.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

74.22% repunte

Estimación a 12 Meses

Media 5 USD 74.22%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

Comprar

Mantener

Vender

De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Compugen Ltd Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.